Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| 1 |
Charles Schwab
SCHW
|
+$1.44B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.06B |
| 3 |
GE HealthCare
GEHC
|
+$519M |
| 4 |
Danaher
DHR
|
+$420M |
| 5 |
American Electric Power
AEP
|
+$387M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$941M |
| 2 |
Boeing
BA
|
+$880M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$819M |
| 4 |
Bank of America
BAC
|
+$705M |
| 5 |
Coca-Cola
KO
|
+$684M |
Sector Composition
| 1 | Healthcare | 16.71% |
| 2 | Technology | 14.92% |
| 3 | Financials | 12.44% |
| 4 | Consumer Discretionary | 11.46% |
| 5 | Industrials | 9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
4851
Corvus Pharmaceuticals
CRVS
$431M
| $196K | ﹤0.01% |
61,676
-17,036
| -22% | -$54.2K |
|
4852
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
$3.15B
| $196K | ﹤0.01% |
3,899
-107,932
| -97% | -$5.42M |
|
4853
RCM Technologies
RCMT
$199M
| $195K | ﹤0.01% |
+12,532
| New | +$195K |
|
|
FDSB
4854
Fifth District Bancorp, Inc. Common Stock
FDSB
$77.2M
| $194K | ﹤0.01% |
15,915
-18,411
| -54% | -$225K |
|
|
ASA
4855
ASA Gold and Precious Metals
ASA
$774M
| $194K | ﹤0.01% |
6,424
+4,189
| +187% | +$126K |
|
4856
Neurogene
NGNE
$253M
| $192K | ﹤0.01% |
+16,416
| New | +$192K |
|
4857
Xoma
XOMA
$444M
| $192K | ﹤0.01% |
9,638
-1,911
| -17% | -$38.1K |
|
4858
Distribution Solutions Group
DSGR
$1.42B
| $191K | ﹤0.01% |
+6,838
| New | +$191K |
|
4859
Cambria Tail Risk ETF
TAIL
$98.7M
| $190K | ﹤0.01% |
16,156
-24,010
| -60% | -$283K |
|
|
LEGT
4860
Legato Merger Corp III
LEGT
$277M
| $190K | ﹤0.01% |
18,137
+5,247
| +41% | +$55K |
|
4861
Asbury Automotive
ABG
$4.77B
| $187K | ﹤0.01% |
848
-16,885
| -95% | -$3.73M |
|
4862
Harvard Bioscience
HBIO
$20.8M
| $187K | ﹤0.01% |
329,964
+261,248
| +380% | +$148K |
|
4863
Austin Gold Corp
AUST
$22.8M
| $186K | ﹤0.01% |
143,114
+104,771
| +273% | +$136K |
|
4864
ProShares Short Real Estate
REK
$10.5M
| $186K | ﹤0.01% |
11,007
-2,490
| -18% | -$42.1K |
|
4865
SoFi Next 500 ETF
SFYX
$26.5M
| $186K | ﹤0.01% |
+13,716
| New | +$186K |
|
4866
Empire State Realty Series ES
ESBA
$2.07B
| $184K | ﹤0.01% |
23,700
+6,348
| +37% | +$49.3K |
|
4867
Smart Sand
SND
$79.5M
| $184K | ﹤0.01% |
71,008
+27,176
| +62% | +$70.4K |
|
4868
DNP Select Income Fund
DNP
$3.7B
| $184K | ﹤0.01% |
18,580
-83,851
| -82% | -$829K |
|
4869
The ONE Group
STKS
$76.5M
| $184K | ﹤0.01% |
61,396
+23,061
| +60% | +$69K |
|
4870
Fuel Tech
FTEK
$94.8M
| $183K | ﹤0.01% |
174,281
-73,275
| -30% | -$76.9K |
|
|
VALN
4871
Valneva
VALN
$856M
| $183K | ﹤0.01% |
27,219
-42,279
| -61% | -$284K |
|
4872
Vivid Seats
SEAT
$110M
| $181K | ﹤0.01% |
3,060
-14,478
| -83% | -$857K |
|
4873
Viemed Healthcare
VMD
$253M
| $181K | ﹤0.01% |
24,867
-21,682
| -47% | -$158K |
|
4874
Lucid Diagnostics
LUCD
$109M
| $181K | ﹤0.01% |
121,430
+1,543
| +1% | +$2.3K |
|
4875
SPDR S&P Pharmaceuticals ETF
XPH
$169M
| $181K | ﹤0.01% |
4,130
-39,683
| -91% | -$1.74M |
|